Skip to search formSkip to main contentSkip to account menu

C3 gene

Known as: CPAMD1, ACYLATION-STIMULATING PROTEIN, C3 
This gene plays a regulatory role in the complement pathway, which is comprised of a complex proteolytic cascade.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2000
Highly Cited
2000
Abstract: The introduction of h‐DAF transgenic porcine organs into pre‐clinical pig‐to‐primate discordant xenotransplantation has… 
Highly Cited
1996
Highly Cited
1996
The proteolytic cleavage product of complement component 3, (C3a), like C4a and C5a, is a potent anaphylatoxin and induces the… 
Highly Cited
1994
Highly Cited
1994
In contrast to C5a, which represents a well-established potent activator of the respiratory burst in polymorphonuclear… 
Highly Cited
1989
Highly Cited
1989
The major secreted proteinase of Entamoeba histolytica, a 56-kDa neutral cysteine proteinase, activates C by cleaving C3. The… 
Review
1984
Review
1984
Chemical and physical characterization of the anaphylatoxin molecules have provided a reasonably clear description of the… 
Highly Cited
1983
Highly Cited
1983
Tryptase, the dominant neutral protease of human pulmonary mast cell secretory granules, has the capacity in vitro to generate… 
Highly Cited
1982
Highly Cited
1982
The C3a fragment of the third component of complement was found to have immunosuppressive properties. C3a is capable of… 
Highly Cited
1978
Highly Cited
1978
Mouse peritoneal macrophages were activated in serum-free culture with lipopolysaccharide, dextran sulphate or C3b. They were… 
Highly Cited
1976
Highly Cited
1976
Human C5a was isolated from complement-activated serum and was characterized for protein and carbohydrate content. The purified…